Evotec (1EVT) Financial Statements
Evotec Financial Overview
Evotec's market cap is currently $500.65M. The company's EPS TTM is $-1.11; its P/E ratio is -2.54; Evotec is scheduled to report earnings on November 5, 2026, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 788.37M | $ 796.97M | $ 781.43M | $ 751.45M | $ 618.03M |
| Gross Profit | $ 65.24M | $ 114.88M | $ 175.05M | $ 174.06M | $ 151.54M |
| Operating Income | $ -140.87M | $ -142.52M | $ -47.51M | $ 12.49M | $ 27.32M |
| EBITDA | $ -41.40M | $ -80.66M | $ 877.00K | $ -86.08M | $ 298.41M |
| Net Income | $ -103.52M | $ -196.08M | $ -83.91M | $ -175.66M | $ 215.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 476.39M | $ 396.80M | $ 604.11M | $ 729.98M | $ 858.50M |
| Total Assets | $ 1.78B | $ 1.91B | $ 2.25B | $ 2.26B | $ 2.24B |
| Total Debt | $ 447.69M | $ 463.10M | $ 626.20M | $ 506.67M | $ 512.92M |
| Net Debt | $ 29.17M | $ 156.71M | $ 115.29M | $ 91.52M | $ -186.41M |
| Total Liabilities | $ 965.05M | $ 959.98M | $ 1.13B | $ 1.07B | $ 857.48M |
| Stockholders' Equity | $ 813.70M | $ 952.52M | $ 1.12B | $ 1.19B | $ 1.38B |
| Cash Flow | |||||
| Free Cash Flow | $ -81.98M | $ -114.02M | $ -179.56M | $ 21.75M | $ 3.29M |
| Operating Cash Flow | $ -9.44M | $ 18.22M | $ 36.44M | $ 203.11M | $ 122.24M |
| Investing Cash Flow | $ 166.42M | $ -71.19M | $ -13.29M | $ -415.82M | $ -243.85M |
| Financing Cash Flow | $ -32.20M | $ -161.42M | $ 71.96M | $ -52.41M | $ 398.43M |
Currency in EUR